![]() |
|
|
Vol. 53, Issue 4, 742-749, April 1998
Departments of Pharmacology (K.R.H., I.J.R.) and Neurobiology (S.R.A., E.A.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
| |
Summary |
|---|
|
|
|---|
Activation of ionotropic glutamate receptors causes increases in intracellular Ca2+ concentration ([Ca2+]i) and intracellular Na+ concentration in neurons. It has been suggested that reversal of the plasma membrane Na+/Ca2+ exchanger (NCE) may account in part for the rise in [Ca2+]i. Recently, KB-R7943 (2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea methanesulfonate) was reported to selectively inhibit the reverse mode of the NCE in non-neuronal cells. We investigated the effects of KB-R7943 on glutamate-stimulated increases in [Ca2+]i. In cultured rat forebrain neurons loaded with indo-1 acetoxymethyl ester, KB-R7943 inhibited the reverse mode of NCE (IC50 = 0.7 µM). When tested against kainate- (100 µM), N-methyl-D-aspartate- (30 µM), glutamate- (3 µM), or KCl- (50 mM) induced [Ca2+]i transients (15 sec, in the presence of Na+ and Ca2+), KB-R7943 inhibited these transients with IC50 values of 6.6, 8.2, 5.2, and 2.9 µM, respectively. [Ca2+]i increases caused by a higher concentration of glutamate (100 µM) also were inhibited by KB-R7943 (10 µM). However, KB-R7943 had no effect on peak [Ca2+]i changes caused by prolonged application of glutamate and did not inhibit glutamate-induced neuronal injury. KB-R7943 did not inhibit N-methyl-D-aspartate- or kainate-induced whole-cell currents, nor did it substantially inhibit voltage-sensitive Ca2+ currents, excluding a direct inhibition of these ion channels. These results suggest that reverse NCE contributes to the immediate rise in [Ca2+]i resulting from glutamate receptor activation. However, reverse NCE becomes less important as the stimulus time is increased, and Ca2+ entry by this route is not critical for the expression of excitotoxic injury.
| |
Introduction |
|---|
|
|
|---|
Neuronal
Ca2+ entry can be mediated directly by NMDA- and
Ca2+-permeable
(±)-
-amino-3-hydroxy-5-methylisoxazole-4-propionic acid/KA receptors and activated indirectly by depolarization-induced activation of voltage-gated Ca2+ channels (Mayer and Miller,
1990
). Because excessive Ca2+ loading induced by
glutamate receptor activation is acutely toxic to neurons (Michaels and
Rothman, 1990
; Hartley et al., 1993
), significant effort has
been directed toward understanding the mechanism underlying
[Ca2+]i increases and
subsequent Ca2+ buffering. In addition to
Ca2+ influx through the glutamate receptors
and/or activation of Ca2+ channels, it has been
proposed that the plasma membrane NCE may contribute to the
glutamate-induced [Ca2+]i
increase (Kiedrowski et al., 1994
; Courtney et
al., 1995
; Kirischuk et al., 1997
). The NCE
electrogenically exchanges 3 Na+ for 1 Ca2+ and can function to cause
Ca2+ accumulation (reverse mode) or
Ca2+ extrusion (forward mode) depending on the
concentrations of each ion on either side of the membrane and on the
membrane potential (Blaustein, 1988
; DiPolo and Beauge, 1988
; Yu and
Choi, 1997
). Because glutamate receptor activation causes a large
increase in [Na+]i, it is
possible that this process, along with membrane depolarization, favors
the influx of Ca2+ via the NCE during the
stimulus. The studies that have investigated the putative contribution
of reversed NCE have been limited by the lack of selective inhibitors
of NCE (Kiedrowski et al., 1994
; Courtney et al.,
1995
; Storozhevykh et al., 1996
; Kirischuk et al., 1997
). As a consequence of this, the role of reverse NCE during glutamate stimulation with physiological
Na+ concentrations is poorly understood. However,
it is clear that forward NCE, along with mitochondrial
Ca2+ uptake, contributes to the buffering of
cytosolic [Ca2+]i after a
glutamate stimulus because recovery is significantly slowed in the
absence of extracellular Na+ (Wang et
al., 1994
; Kiedrowski and Costa, 1995
; White and Reynolds, 1995
).
It also has been suggested that extrusion of Ca2+
via the NCE serves an important neuroprotective function because inhibition of this process increases neuronal death after a toxic glutamate stimulus (Hartley and Choi, 1989
; Andreeva et al.,
1991
).
Recently, KB-R7943
(2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea
methanesulfonate) was shown to selectively inhibit the reverse mode of
the NCE. (Iwamoto et al., 1996
; Watano et al.,
1996
). KB-R7943 inhibits reverse NCE (IC50 = 1.2-2.4 µM) in a number of cell types, including
cardiomyocytes, smooth muscle cells, and NCX1-expressing fibroblasts
(Iwamoto et al., 1996
). The affinity for inhibition of the
reverse mode of NCE is
10-fold higher than that required to inhibit
the forward mode (Iwamoto et al., 1996
). KB-R7943 does
inhibit dihydropyridine-sensitive Ca2+channels
but at concentrations
10-fold higher than those required to inhibit
reverse NCE (Iwamoto et al., 1996
).
In this study, we used KB-R7943 to elucidate the contribution of reverse NCE to the increase in [Ca2+]i after glutamate stimulation of cultured forebrain neurons. We developed a stimulation paradigm to assay reverse NCE in intact neurons and confirmed the activity of KB-R7943 on this process and report that reverse NCE makes a substantial contribution to the initial increase in [Ca2+]i caused by glutamate receptor activation. However, this contribution is diminished progressively during longer glutamate exposures, with the result that inhibition of reverse NCE does not seem to be neuroprotective in vitro.
| |
Experimental Procedures |
|---|
|
|
|---|
Primary neuronal culture.
For
[Ca2+]i measurements,
forebrains from e17 Sprague-Dawley rats were removed, dissociated, and
plated at a density of 3 × 105 cells/ml
onto 31-mm glass coverslips in 35-mm six-well culture plates, as
described in detail previously (White and Reynolds, 1995
). All
procedures using animals were in strict accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals and the Use Committee of the University of Pittsburgh.
Dissociated neurons initially were plated in DMEM with 10% fetal
bovine serum, 24 units/ml penicillin, and 24 µg/ml streptomycin.
Twenty-four hours after plating, the media were removed and replaced
with DMEM with horse serum instead of fetal bovine serum, and the
coverslips were inverted. Coverslip inversion suppresses proliferation
of non-neuronal cells. Neuronal cultures were kept at 37° in a 5%
CO2 incubator until use (12-18 days).
[Ca2+]i measurements.
Recordings
of [Ca2+]i in individual
neurons were made in indo-1-loaded neurons as described previously
(White and Reynolds, 1995
). Cells were rinsed with HBSS that contained
137 mM NaCl, 5 mM KCl, 0.9 mM
MgSO4, 1.4 mM
CaCl2, 3 mM
NaHCO3, 0.6 mM
Na2HPO4, 0.4 mM
KH3PO4, 5.6 mM
glucose, and 20 mM HEPES, pH adjusted to 7.4 with NaOH, and
then incubated in HBSS containing the
Ca2+-sensitive fluorescent dye indo-1-AM (5 µM) and 5 mg/ml bovine serum albumin at 37° for 50 min.
The cells were washed with dye-free HBSS and returned to the 37°
incubator for an additional 20 min. The coverslip containing dye-loaded
neurons was mounted in a recording chamber and placed on the stage of a
Nikon Diaphot fluorescence microscope. Neurons were perfused with HBSS
or drug solutions at a rate of 20 ml/min. Indo-1 fluorescence was
measured by isolating a single neuron with a rectangular diaphragm
in the emission pathway. Ratios of indo-1 fluorescence obtained at 405 and 490 nm (excitation, 340 nm) were used to calculate
[Ca2+]i using in
situ calibration parameters as described previously (White and
Reynolds, 1997
). For Na+-free HBSS experiments,
the Na+ was replaced with
N-methyl-D-glucamine, the
NaHCO3 was replaced with
KHCO3, and the KCl was omitted. For
IC50 determinations of averaged data, data were
fit with a four-parameter logistic equation using Prism Version 2.01 (GraphPAD Software, San Diego, CA).
Whole-cell recording. Electrophysiological measurements were obtained using the whole-cell patch-clamp configuration. Results are expressed as the mean ± standard error. Whole-cell recording reagents were purchased from Sigma Chemical (St. Louis, MO) except as noted.
For ligand-gated ion channels (NMDA and KA), the methods of data acquisition and analysis have been described previously (Aizenman et al., 1992
) were filled with 140 mM CsF, 10 mM EGTA, 1 mM
CaCl2, and 10 mM HEPES, pH 7.2. NMDA
and KA were dissolved in extracellular solution and applied onto cells
by a multibarrel fast-perfusion system (Warner Instrument, Hamden, CT).
For voltage-gated Ca2+ channels, currents were
evoked by a depolarizing step from
80 to 0 mV. Series
resistance was compensated and leak currents were subtracted with the
use of a prepulse protocol. Depolarizing steps were made once every 5 or 10 sec to avoid inactivation of Ca2+ currents.
The external recording solution contained 140 mM NaCl, 5 mM CaCl2, 2 mM
MgCl2, 10 mM HEPES, pH 7.2, 5 mM glucose, 10 mM tetraethylammonium·HCl, 1 µM tetrodotoxin, and 5 mM KCl. Patch electrodes (2-3 M
) were filled with 108 mM CsCl, 9 mM EGTA, 4.5 mM MgCl2, 9 mM HEPES, pH 7.2, 4 mM Mg·ATP, 0.3 mM Na3·GTP, and 14 mM
Na2·phosphocreatine. Electrodes were "tip
dipped" for
20 sec in intracellular solution that did not contain
ATP, GTP, or phosphocreatine.
Materials. Indo-1-AM and magfura-2-AM were purchased from Molecular Probes (Eugene, OR). DMEM, MEM, penicillin, and streptomycin were purchased from GIBCO BRL (Grand Island, NY). Glutamate, glycine, NMDA, and KA were purchased from Sigma Chemical (St. Louis, MO). KB-R7943 was a generous gift of Dr. Tomokazu Watano (Kanebo, Osaka, Japan).
| |
Results |
|---|
|
|
|---|
To assay the putative activity of KB-R7943, we first established a
paradigm to selectively activate Ca2+ influx into
indo-1-loaded neurons via reverse NCE. This paradigm is illustrated in
Fig. 1A. Neurons were loaded with
intracellular Na+ in the absence of extracellular
Ca2+ using NMDA receptor activation (30 µM NMDA/1 µM glycine for 1 min) (Stout
et al., 1996
). NMDA was removed, and the cells were washed
with Ca2+-free HBSS for 2 min. The subsequent
reintroduction of extracellular Ca2+ and the
removal of extracellular Na+ (replaced with
N-methyl-D-glucamine) resulted in a large
increase in [Ca2+]i that
presumably was the result of reverse NCE. This influx was inhibited
effectively by treatment with 1 µM KB-R7943 (Fig. 1A). We
tested the effects of increasing concentrations of KB-R7943 (0.01-10
µM) on this reverse NCE paradigm (Fig. 1B), and these data are summarized in Fig. 1C. The effect of KB-R7943 was partially reversible after washout of the drug at the end of the experiment (Fig.
1B). The calculated IC50 value for inhibition of
reverse NCE by KB-R7943 was 0.70 ± 0.08 µM, which
is comparable to values obtained in cardiomyocytes (Iwamoto et
al., 1996
). We did not compensate for the partial reversibility of
KB-R7943 in calculation of the IC50 because it is
a relatively small effect. In addition, a similar degree of inhibition
and reversibility was seen in cells that were treated with only 10 µM KB-R7943, which indicates that the inhibition is
unlikely to result from cumulative incomplete reversal.
|
We then tested the effect of KB-R7943 on the forward mode of NCE.
Because it has been demonstrated that forward NCE is responsible, in
part, for the recovery of
[Ca2+]i after a glutamate
stimulus (White and Reynolds, 1995
), we tested the effect of KB-R7943
on this recovery. In this series of experiments (Fig.
2), we exposed neurons to two short
(15-sec) pulses of 3 µM glutamate and manipulated the
recovery during the 2 min immediately after the second glutamate
stimulus. Fig. 2A is a control that shows that the responses are
reproducible within a given cell. Fig. 2B shows that removal of
extracellular Na+ (to inhibit forward NCE)
significantly slows Ca2+ recovery, which is in
agreement with our previous results (White and Reynolds, 1995
). A drug
that inhibits forward NCE would be expected to mimic the effects of
Na+ removal in this paradigm. KB-R7943 (30 µM) did tend to slow Ca2+ recovery
(Fig. 2C) but not to the same degree as Na+
removal, suggesting that KB-R7943 is not as an effective inhibitor of
forward NCE as Na+ removal at the concentration
tested. These data are summarized in Fig. 2D, where the recovery time
is expressed as time to twice basal
[Ca2+]i levels. The
limited inhibition of forward NCE observed with a relatively high
concentration of KB-R7943 does not allow us to determine the precise
ratio of the potency of KB-R7943 for the forward compared with the
reverse mode because we cannot determine an IC50
value for the forward mode.
|
We next sought to determine whether stimuli in normal HBSS result in
Ca2+ influx that is partially or wholly mediated
through reverse NCE. We tested the effect of KB-R7943 on NMDA-,
non-NMDA-, and depolarization-induced [Ca2+]i increases (Fig.
3). Fig. 3A shows a representative
[Ca2+]i trace from a
neuron exposed repeatedly to 30 µM NMDA/1
µM glycine for 15 sec (in HBSS containing
Na+ and Ca2+). Pretreatment
with increasing concentrations of KB-R7943 (0.01-30 µM)
results in inhibition of these NMDA-induced
[Ca2+]i increases, and
the inhibitory effect of KB-R7943 is partially reversible after washout
of drug at the end of the experiment. These data are summarized in Fig.
3B, which also shows that KB-R7943 has a similar inhibitory effect if 3 µM glutamate is used as the [Ca2+]i-increasing
agonist. This concentration of glutamate causes a
Ca2+ influx that is mostly mediated by NMDA
receptor activation (Rajdev and Reynolds, 1994
). Fig. 3C shows the
effect of KB-R7943 on KA-induced (100 µM) and
depolarization-induced (50 mM KCl)
[Ca2+]i increase when
tested in the same paradigm as Fig. 3A. Overall, KB-R7943 inhibited 30 µM NMDA-, 3 µM glutamate-, 100 µM KA-, and 50 mM KCl-induced
[Ca2+]i increases with
IC50 values of 8.2 ± 1.7, 5.2 ± 0.6, 6.6 ± 1.7, and 2.9 ± 0.5 µM, respectively,
which suggests that a significant component of the acute
[Ca2+]i change in
response to each of these stimuli occurs via reverse NCE.
|
The effects of KB-R7943 on reverse NCE were established under conditions in which the agonist had been washed out, so direct receptor inhibition could not reasonably account for the effects seen. However, when the inhibitor was applied in normal buffer, direct inhibition of glutamate receptors could underlie the inhibition of Ca2+ transients. To address this possibility, we tested the effect of this drug on whole-cell currents activated by NMDA or KA (Fig. 4). KB-R7943 (30 µM), at a concentration that almost completely inhibited agonist-induced Ca2+ transients, was added to neurons in the continuous presence of either KA (30 µM; Fig. 4A) or NMDA (30 µM; Fig. 4B). It is apparent from these representative traces that KB-R7943 does not appreciably inhibit these currents. For KA-induced currents, 10 or 30 µM KB-R7943 potentiated the response by 7.6 ± 2.5% (p = 0.02, significantly different from untreated control, Student's t test; seven neurons in total) or 1.8 ± 0.8% (p > 0.05, not different from untreated control, Student's t test; five neurons/condition), respectively. For NMDA-induced currents, 10 or 30 µM KB-R7943 did not significantly alter responses [decreased by 1.9 ± 1.6% (seven neurons/condition) or 2.4 ± 0.9% (three neurons/condition) respectively, p > 0.05, not different from untreated control, Student's t test]. These results suggest that direct receptor inhibition is not responsible for the effects of KB-R7943 on [Ca2+]i increases caused by NMDA or KA receptor activation.
|
Another important Ca2+ influx pathway is the
activation of voltage-sensitive Ca2+ channels.
KB-R7943, at relatively high concentrations, has been shown previously
to inhibit these channels in heart cells (35% inhibition at 30 µM) (Iwamoto et al., 1996
). Such an inhibitory effect, if present, potentially could account for the inhibitory effect
of KB-R7943 on the glutamate- or depolarization-induced [Ca2+]i changes. We
therefore tested the effect of KB-R7943 on neuronal voltage-sensitive
Ca2+ currents (Fig. 4C). Whole-cell
voltage-sensitive Ca2+ currents evoked by a
depolarizing step from
80 to 0 mV were inhibited 7.7 ± 2.4% by
10 µM KB-R7943 (Fig. 4C; p < 0.05, significantly different from untreated control, Student's t
test; six neurons/condition). A higher concentration of KB-R7943 (30 µM) inhibited currents by 24.3 ± 1.1%
(p < 0.05, significantly different from
untreated control, Student's t test; 12 neurons/condition).
Clearly, although KB-R7943 did inhibit voltage-sensitive
Ca2+ channels, the magnitude of this inhibition
is not sufficient to explain the much more substantial inhibitory
effect of KB-R7943 on
[Ca2+]i increases caused
by glutamate receptor activation or depolarization (see Fig. 3).
Additional predictions can be made based on the proposed action of
KB-R7943. Previous work has shown that exposure of neurons to
Na+-free HBSS for 15 min results in the depletion
of intracellular Na+ (Stout et al.,
1996
). Reverse NCE should be inactive under conditions of low
[Na+]i. However, KA still
can increase [Ca2+]i in
the absence of Na+ because of the presence of
Ca2+-permeable KA receptors in these cells (Hoyt
et al., 1995
). This KA-induced
[Ca2+]i increase in the
absence of Na+, although substantial (2.1 ± 0. 8 µM, four neurons/condition), is significantly
smaller than KA-induced
[Ca2+]i increases in the
presence of Na+ (6.6 ± 1.3 µM; p < 0.05, Student's t
test; five neurons/condition). Fig. 5A
shows that KB-R7943 (10 µM) does not inhibit KA-induced [Ca2+]i increases in
neurons that have been depleted of intracellular Na+. In fact, KB-R7943 potentiated this response
(148 ± 16% of untreated control; p = 0.03, significantly different from control, Student's t test; six
neurons/condition). These data further support that the action of
KB-R7943 is on reverse NCE and not a direct inhibitory effect on
receptor activation. Also, these results suggest that KB-R7943 itself
does not directly interfere with the ability of indo-1 to record
[Ca2+]i in our cells.
|
We next looked at the effect of KB-R7943 on a higher concentration of
glutamate to evaluate the contribution of reverse NCE to excitotoxic
Ca2+ loads. KB-R7943 (10 µM, 30-sec
pretreatment and included with agonist) inhibited the peak
[Ca2+]i increase caused
by 100 µM glutamate/1 µM glycine for 15 sec (41.0 ± 6.6% of untreated control; Fig.
6A; five neurons/condition), and this
effect was partially reversible. The time required for [Ca2+]i to return to
twice basal levels after 100 µM glutamate (for 15 sec)
removal was significantly decreased by KB-R7943 treatment (recovery
time, 23.0 ± 5.6% compared with untreated control recovery time;
five neurons/condition), which is consistent with a decreased [Ca2+]i load. We also
investigated the effect of KB-R7943 on the
[Ca2+]i changes caused by
longer glutamate exposures. For these experiments, we used mag-Fura-2
(a low Ca2+ affinity
[Ca2+]i indicator) as an
indication of [Ca2+]i
instead of indo-1 because these prolonged glutamate exposures caused
[Ca2+]i increases that
frequently saturated the indo-1 signal. Fig. 6B demonstrates the effect
of a low concentration of glutamate (3 µM for 15 sec, for
comparison purposes) followed 15 min later by a 5-min exposure to 100 µM glutamate. The effect of KB-R7943 (10 µM) on this prolonged glutamate response is shown in Fig. 6C. It is evident that although there is an initial attenuation of the
[Ca2+]i response
immediately after the addition of 100 µM glutamate in the
presence of KB-R7943 (the ratio change at 15 sec is 69.2 ± 7.9%
of the corresponding 3 µM glutamate response in the same cell), the peak ratio change during the 5-min exposure is not different
from untreated control (0.24 ± 0.08 ratio units for untreated
control versus 0.38 ± 0.11 ratio units for KB-R7943-treated neurons, eight neurons/condition). Also, the recovery time (to basal
ratio) after removal of 100 µM glutamate was not
significantly different in KB-R7943-treated neurons compared with
untreated controls (KB-R7943-treated, 674.8 ± 43.1 sec; untreated
controls, 787.7 ± 99.3 sec; eight neurons/condition). Finally, we
considered whether KB-R7943 could protect neurons from glutamate
excitotoxicity. We found that 10 µM KB-R7943 was not
neurotoxic alone (88.2 ± 10.4% viability, four
neurons/condition) and did not protect neurons from the cell death
caused by 100 µM glutamate for 10 min [resulting in
53.7 ± 5.2% viability caused by glutamate alone compared with 46.0 ± 5.3% viability in the presence of KB-R7943, 20 hr after exposure (four neurons/condition) measured by retention of the vital
dye calcein (Bozyczko-Coyne et al., 1993
)]. Also,
activation of reverse NCE (identical to the paradigm described in Fig.
1) did not induce neuronal death (103 ± 5.8% viability, three
neurons/condition) when measured 20 hr after exposure. These data
suggest that although KB-R7943 is an effective inhibitor of short
glutamate exposures, its inhibitory effect eventually is overcome by
longer agonist exposure because the contribution made by direct
Ca2+ influx through NMDA receptors [the receptor
subtype predominately activated by glutamate (Rajdev and Reynolds,
1994
) and responsible for glutamate neurotoxicity (Choi et
al., 1987
)] ultimately is more substantial than that meditated by
reverse NCE.
|
| |
Discussion |
|---|
|
|
|---|
The findings described in this study show that reverse
operation of the NCE contributes substantially to the increase in
[Ca2+]i caused by
glutamate receptor activation in central neurons in the presence of
physiological extracellular [Na+] and
extracellular [Ca2+]. It has been hypothesized
previously that reverse NCE contributes to these changes in
[Ca2+]i, but it has been
difficult to test this hypothesis rigorously given the lack of specific
inhibitors. The use of the selective inhibitor of reverse NCE KB-R7943
allowed us to evaluate the role of this exchanger in the
[Ca2+]i changes caused by
glutamate receptor activation. That KB-R7943 is an inhibitor of reverse
NCE has been established in studies with cardiomyocytes (Iwamoto
et al., 1996
). We confirmed this action in cultured neurons
(Fig. 1) and also demonstrated that it is not an effective inhibitor of
forward NCE (Fig. 2) in these cells. Our observation that the initial
[Ca2+]i change is
completely blocked by KB-R7943 is surprising and argues that the
[Ca2+]i change does not
predominantly arise from direct Ca2+ entry. It is
possible that there also is an effect related to local
[Ca2+]i changes within
cells, so the reverse NCE pathway may be more prominent in soma than
dendrites. However, we cannot resolve this effect with the techniques
used in this study.
Because KB-R7943 was such an effective inhibitor of NMDA-, non-NMDA-,
and depolarization-induced increases in
[Ca2+]i, we were
concerned that KB-R7943 may have inhibitory effects on receptor
function independent of effects on reverse NCE. However, this does not
seem to be the case because KB-R7943 did not inhibit NMDA- or
KA-induced whole-cell currents. The KA-induced whole-cell current was
slightly, but significantly, increased by KB-R7943. In addition,
KB-R7943 potentiated KA-induced
[Ca2+]i increases
(mediated by Ca2+-permeable
(±)-
-amino-3-hydroxy-5-methylisoxazole-4-propionic acid/KA
receptors) when cells were depleted of intracellular
Na+. It is unclear whether the small potentiation
of KA-induced currents and the larger potentiation of KA-induced
[Ca2+]i increases in the
absence of [Na+]i are
related because the mechanism of this potentiation is not understood at
this point.
We were concerned in the case of KA- and depolarization-induced
Ca2+ increases that the inhibitory effect of
KB-R7943 involved inhibition of voltage-sensitive
Ca2+ channels because KB-R7943 can inhibit these
channels in cardiomyocytes at relatively high concentrations (35%
inhibition at 30 µM) (Iwamoto et al., 1996
).
When we tested the effect of KB-R7943 on neuronal voltage-sensitive
Ca2+ currents, we found that it does have a
relatively small inhibitory effect. The magnitude of this inhibition
(e.g., 24% at 30 µM KB-R7943), however, cannot account
for the nearly complete blockade of
[Ca2+]i increases we
demonstrated, further strengthening the conclusion that the action of
KB-R7943 on glutamate receptor-mediated or depolarization-induced
[Ca2+]i increases is
inhibition of reverse NCE. Other potential
[Ca2+]i regulatory
mechanisms that could be affected by KB-R7943 include Ca2+-induced Ca2+ release
and the mitochondrial NCE. We previously investigated the contribution
of Ca2+-induced Ca2+
release to glutamate-induced Ca2+ responses in
our cell culture preparation (Reynolds, 1996
). This process seems to
make, at best, a small contribution to our responses and thus is
unlikely to be the site of action of KB-R7943. We also do not believe
that KB-R7943 inhibits mitochondrial NCE. We have shown previously that
a drug (CGP-37157) that blocks mitochondrial NCE causes a rapid
recovery from glutamate-induced Ca2+ increases
due to blockade of mitochondrial Ca2+ efflux,
which contributes to the Ca2+ measured during
recovery (White and Reynolds, 1997
). KB-R7943 had little effect on
Ca2+ recovery (Fig. 2). Also, if KB-R7943 were
blocking mitochondrial NCE, one would expect a rise in
Ca2+ as the KB-R7943 is washed out, reflecting
efflux of Ca2+ stored in the mitochondria. We
never saw such an effect of KB-R7943.
When we extended the exposure time to glutamate, we found that
although the initial
[Ca2+]i increase was
inhibited by KB-R7943, the ultimate levels to which
[Ca2+]i rose during the
longer glutamate exposure were not different from those of untreated
controls. Also, the time for the cell to recover from the longer
glutamate exposure was not shortened by including KB-R7943 with the
glutamate, suggesting that the glutamate imposed a quantitatively
similar [Ca2+]i load on
the cell. For these prolonged glutamate exposures, we used magfura-2
instead of indo-1 because the indo-1 signal often became saturated
during the stimulus. The use of magfura-2 allows us to more reliably
estimate high [Ca2+]i
because it has a lower affinity for Ca2+ than
does indo-1 (Grynkiewicz et al., 1985
; Raju et
al., 1989
; Hurley et al., 1992
). Magfura-2 also detects
[Mg2+]i, which has been
reported to increase during glutamate exposure, but this
Mg2+ increase mainly is dependent on
Ca2+ influx (Rajdev and Reynolds, 1995
) and
therefore is an additional indication of the magnitude of
Ca2+ increase in these cells. Overall, these data
lead us to conclude that although reverse NCE is a prominent route of
Ca2+ influx during short glutamate exposures,
other routes of Ca2+ entry or
Ca2+ buffering become more important as the
stimulus duration increases, possibly because as
Ca2+ accumulates in the cytoplasm, the gradient
for Ca2+ influx through the NCE decreases or
Ca2+ buffering simply becomes overwhelmed. This
conclusion is supported by the recent report that exposure of neurons
to glutamate for 3-5 min ultimately leads to an inhibition of reverse
NCE when measured after glutamate removal (Yu and Choi, 1997
).
Consistent with the finding that KB-R7943 does not block glutamate-induced [Ca2+]i increases for the duration of a prolonged glutamate exposure, we found that KB-R7943 was not an effective inhibitor of glutamate-induced neuronal death. This suggests that the Ca2+ influx through the NCE is not a substantial contributor to the Ca2+ load that ultimately leads to induction of cell death. Simple activation of reverse NCE also did not kill cells, supporting this conclusion. Therefore, the primary source of Ca2+ that causes neuronal death must be excessive influx through glutamate-activated channels.
KB-R7943 was somewhat more potent as an inhibitor of the reverse NCE
paradigm (Fig. 1) than as a blocker of NMDA-, non-NMDA-, or
depolarization-induced
[Ca2+]i increases (Fig.
3). The basis for the difference in potency between assay paradigms is
not entirely clear. There clearly is a marked difference in the
[Na+]i at the point of
drug addition. There also may be a difference in the maximal
[Na+]i reached during the
different paradigms, as well as a differing degree of depolarization.
Finally, in the reverse NCE paradigm, the
[Ca2+]e is much lower
when the inhibitor is first applied to the cells. If KB-R7943 inhibits
reverse NCE by binding to the extracellular Ca2+
recognition site, as proposed by Watano et al. (1996)
, the
latter difference between the two assays could account for the
difference in potency.
In summary, we conclude that reverse NCE is an important contributor to the early [Ca2+]i increase caused by NMDA and non-NMDA receptor activation. KB-R7943 inhibited [Ca2+]i increases caused by acute, but not prolonged, glutamate receptor activation and correspondingly did not inhibit glutamate-induced cell death. These findings suggest that although reverse NCE certainly is involved in some of the increase in [Ca2+]i caused by glutamate receptor activation, its role may be limited to short, more physiological stimuli and not prolonged pathophysiological ones.
| |
Acknowledgments |
|---|
We thank Kristi Rothermund and Chialin Cheng for preparing the neuronal cultures, Heather Raphael and Dr. Amy Stout for assistance with toxicity experiments, and Jim Dilmore for his generous assistance with recording voltage-sensitive Ca2+ currents. KB-R7943 was a generous gift of Dr. Tomokazu Watano (Kanebo, Osaka, Japan).
| |
Footnotes |
|---|
Received September 11, 1997; Accepted December 12, 1997
This work was supported by National Institutes of Health Grants NS34138 and NS29365 and by the American Heart Association. S.R.A. is supported by National Institutes of Health Training Grant MH18273. I.J.R. is an Established Investigator of the American Heart Association.
Send reprint requests to: Ian J. Reynolds, Ph.D., Department of Pharmacology, University of Pittsburgh School of Med., E1354 Biomedical Science Tower, Pittsburgh, PA 15261. E-mail: ijr{at}prophet.pharm.pitt.edu
| |
Abbreviations |
|---|
NMDA, N-methyl-D-aspartate;
NCE, plasma membrane
Na+/Ca2+ exchanger;
DMEM, Dulbecco's modified
Eagle's medium;
MEM, minimal essential medium;
HBSS, HEPES-buffered
salt solution;
EGTA, ethylene glycol bis(
-aminoethyl
ether)-N,N,N',N'-tetraacetic
acid;
DMEM, Dulbecco's modified Eagle's medium;
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;
AM, acetoxymethyl
ester;
KA, kainate;
[Na+]i, intracellular
Na+ concentration;
[Ca2+]i, intracellular Ca2+ concentration.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. A. Vander Jagt, J. A. Connor, and C. W. Shuttleworth Localized Loss of Ca2+ Homeostasis in Neuronal Dendrites Is a Downstream Consequence of Metabolic Compromise during Extended NMDA Exposures J. Neurosci., May 7, 2008; 28(19): 5029 - 5039. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Pedersen, M. E. O'Donnell, S. E. Anderson, and P. M. Cala Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl- cotransport in the heart, brain, and blood Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R1 - R25. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kartvelishvily, M. Shleper, L. Balan, E. Dumin, and H. Wolosker Neuron-derived D-Serine Release Provides a Novel Means to Activate N-Methyl-D-aspartate Receptors J. Biol. Chem., May 19, 2006; 281(20): 14151 - 14162. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Luo, H. Chen, D. B. Kintner, G. E. Shull, and D. Sun Decreased Neuronal Death in Na+/H+ Exchanger Isoform 1-Null Mice after In Vitro and In Vivo Ischemia J. Neurosci., December 7, 2005; 25(49): 11256 - 11268. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Kintner, A. Look, G. E. Shull, and D. Sun Stimulation of astrocyte Na+/H+ exchange activity in response to in vitro ischemia depends in part on activation of ERK1/2 Am J Physiol Cell Physiol, October 1, 2005; 289(4): C934 - C945. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwamoto, S. Kita, A. Uehara, I. Imanaga, T. Matsuda, A. Baba, and T. Katsuragi Molecular Determinants of Na+/Ca2+ Exchange (NCX1) Inhibition by SEA0400 J. Biol. Chem., February 27, 2004; 279(9): 7544 - 7553. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsumoto, S. Yamamoto, Y. Suzuki, T. Tsuboi, S. Terakawa, N. Ohashi, and K. Umemura Na+/H+ Exchanger Inhibitor, SM-20220, Is Protective Against Excitotoxicity in Cultured Cortical Neurons Stroke, January 1, 2004; 35(1): 185 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hurtado, S. Borges, and M. Wilson Na+-Ca2+ Exchanger Controls the Gain of the Ca2+ Amplifier in the Dendrites of Amacrine Cells J Neurophysiol, November 1, 2002; 88(5): 2765 - 2777. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brini, S. Manni, and E. Carafoli Recombinant Expression of the Plasma Membrane Na+/Ca2+ Exchanger Affects Local and Global Ca2+ Homeostasis in Chinese Hamster Ovary Cells J. Biol. Chem., October 4, 2002; 277(41): 38693 - 38699. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Michel, J. Itri, and C. S. Colwell Excitatory Mechanisms in the Suprachiasmatic Nucleus: The Role of AMPA/KA Glutamate Receptors J Neurophysiol, August 1, 2002; 88(2): 817 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Doi, Y. Kakazu, and N. Akaike Na+/Ca2+ Exchanger in GABAergic Presynaptic Boutons of Rat Central Neurons J Neurophysiol, April 1, 2002; 87(4): 1694 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shigekawa and T. Iwamoto Cardiac Na+-Ca2+ Exchange : Molecular and Pharmacological Aspects Circ. Res., May 11, 2001; 88(9): 864 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwamoto, S. Kita, A. Uehara, Y. Inoue, Y. Taniguchi, I. Imanaga, and M. Shigekawa Structural Domains Influencing Sensitivity to Isothiourea Derivative Inhibitor KB-R7943 in Cardiac Na+/Ca2+ Exchanger Mol. Pharmacol., March 1, 2001; 59(3): 524 - 531. [Abstract] [Full Text] |
||||
![]() |
|